Equities

Xtant Medical Holdings Inc

Xtant Medical Holdings Inc

Actions
  • Price (EUR)0.545
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-50.45%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:01 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5.722018
Total Receivables, Net21117.15
Total Inventory371718
Prepaid expenses1.330.670.84
Other current assets, total0.210.210.14
Total current assets654944
Property, plant & equipment, net107.176.47
Goodwill, net7.303.213.21
Intangibles, net100.340.40
Long term investments------
Note receivable - long term------
Other long term assets0.140.200.29
Total assets936055
LIABILITIES
Accounts payable7.053.492.62
Accrued expenses115.954.81
Notes payable/short-term debt000
Current portion long-term debt/capital leases4.695.773.65
Other current liabilities, total------
Total current liabilities231511
Total long term debt179.8712
Total debt221616
Deferred income tax0.02----
Minority interest------
Other liabilities, total0.970.970.84
Total liabilities412624
SHAREHOLDERS EQUITY
Common stock0.000.000.00
Additional paid-in capital294278266
Retained earnings (accumulated deficit)(243)(244)(235)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.030.000.00
Total equity513431
Total liabilities & shareholders' equity936055
Total common shares outstanding13010987
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.